Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Natriuretic peptide replacements are engineered molecules designed to replicate or enhance the beneficial cardiovascular/renal actions of natural NPs through activation of specific guanylyl cyclase-coupled receptors leading to increased cGMP signaling. Ongoing research aims at optimizing these agents’ pharmacokinetics/dynamics for safer long-term use across various cardiorenal diseases.
Activation of particulate guanylyl cyclase receptors (NPR-A/B), leading to increased intracellular cGMP, vasodilation, and enhanced renal sodium/water excretion.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Natriuretic Peptide Replacements (N/A).